Indian insect protein firm plans to spend Series A funding on commercial-scale facility.
- ByStartupStory | November 5, 2025
Indian Insect Protein Startup Loopworm to Use Series A Funding to Build Commercial-Scale Facility
Bengaluru-based alternative protein startup Loopworm has announced it will deploy its recently raised Series A funding to establish its first commercial-scale insect protein production facility. The funding round, co-led by WaterBridge Ventures and Japanese ENRISSION INDIA CAPITAL, injects fresh capital as the company aims to scale up sustainable insect farming technologies that convert organic waste into high-quality protein and oil for aquaculture and animal feed markets.
Loopworm pioneered a novel “reactor-free” biomanufacturing platform using engineered silkworms as living factories to produce recombinant proteins. This approach is faster, more cost-effective, and environmentally friendly compared to conventional bioreactor systems. The startup currently runs a 6,000-tonne-per-year insect processing pilot facility and exports protein ingredients to markets in Europe, South America, and Southeast Asia.
The new commercial facility, located in North Bengaluru, will enable Loopworm to meet rising global demand for sustainable protein alternatives while advancing its biopharmaceutical recombinant protein production pipeline targeting diagnostics and vaccines.
Co-founder and CEO Ankit Alok Bagaria highlighted that the company’s vision is to combine sustainability with innovation, aiming to position India as a leader in biotech innovation beyond IT. The commercial-scale plant will be a leap in production capacity and will facilitate expanded R&D and regulatory compliance for emerging markets.
Loopworm’s insect protein products received regulatory approval from the Coastal Aquaculture Authority of India earlier this year, allowing them to be used as additives in aquaculture feed, a critical milestone supporting market adoption.
With the Series A funding fueling facility build-out and innovation, Loopworm is poised to accelerate growth as the global demand for alternative proteins continues to surge amid sustainability and food security concerns.
In summary, Loopworm’s Series A funding will support establishing the commercial production facility crucial to scaling its insect protein technology, underpinning India’s emergence as a hub for sustainable biomanufacturing and novel protein solutions.
Follow Startup Story
Related Posts
